婴儿喉软化症中抗酸药物与声门上成形术的关联
这项回顾性队列研究纳入2014至2023年一家三级儿科医院耳鼻咽喉气道门诊的395例6月龄以下非重度喉软化症婴儿,比较观察组320例与胃食管反流病(GERD)药物组75例的声门上成形术频率;总体手术率为4.1%(16/395),观察组3.4% vs 药物组6.7%(差值-3.2%,95%CI -10%至3.6%),估计不精确无法定论。
要点
- 非重度喉软化症婴儿总体声门上成形术率为4.1%(16/395)。
- 观察组手术率3.4% vs GERD药物组6.7%,差值-3.2%(95%CI -10%至3.6%)。
- 女性及内镜下喉软化严重程度是观察期后接受声门上成形术的最佳预测因素。
核心结论
- 非重度喉软化症婴儿中,GERD药物治疗者与无 reflux 观察等待者的声门上成形术率相似。
- 女性及基于内镜检查的喉软化严重程度是观察等待后接受声门上成形术的最佳预测因素。
研究设计与样本
- 回顾性队列研究,纳入2014至2023年一家三级儿科医院小儿耳鼻咽喉气道门诊的6月龄以下临床诊断非重度喉软化症婴儿。
- 共分析395例婴儿(女171例,男224例),初始管理为观察等待或GERD药物。
- 观察组320例,GERD药物试验组75例,两组基线特征相似。
主要发现
- 总体声门上成形术率为4.1%(16/395)。
- 观察组声门上成形术率3.4% vs GERD药物组6.7%,差值-3.2%(95%CI -10%至3.6%)。
- 估计的不精确性妨碍就观察到的差异做出确定性结论。
局限性
- 原文指出估计的不精确性妨碍就观察到的差异做出确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acid suppression therapy is frequently administered to infants with laryngomalacia presenting with stridor despite limited evidence in the literature reporting its efficacy for this subset of patients. OBJECTIVE: To evaluate the frequency of supraglottoplasty in infants with nonsevere laryngomalacia treated with gastroesophageal reflux disease (GERD) medications. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included infants younger than 6 months with a clinical diagnosis of nonsevere laryngomalacia initially managed with either watchful waiting or GERD medications. Patients were recruited from 2014 to 2023 to a pediatric otolaryngology airway clinic at a tertiary care pediatric hospital. MAIN OUTCOMES AND MEASURES: The primary outcome was the frequency of supraglottoplasty following nonsurgical management. Patients with nonsevere laryngomalacia were divided into 2 groups based on whether their laryngomalacia was managed with GERD medication therapy or observation alone. The aim was to assess the difference in supraglottoplasty rates between these 2 groups. RESULTS: The medical records of 395 infants younger than 6 months (171 female, 224 male) with nonsevere laryngomalacia managed with observation after their initial otolaryngology evaluation were analyzed: observation (n = 320) and trial of GERD medications (n = 75). Baseline characteristics between the observation and GERD medication groups were similar. The overall supraglottoplasty rate was 4.1% (16/395), with a small increase in the use of surgical treatment between the observation and GERD medication cohorts (3.4% vs 6.7%; difference, -3.2% [95% CI, -10% to 3.6%]). The imprecision in the estimate prevents making a definitive conclusion regarding the observed difference. CONCLUSIONS: This study found that rates of supraglottoplasty in infants with nonsevere laryngomalacia with GERD managed with GERD medications were similar to those without reflux managed with watchful waiting. Female sex and severity of laryngomalacia based on endoscopic examination were the best predictors of receipt of supraglottoplasty after a period of watchful waiting.
引用
- Zalzal H, Pershad A, Behzadpour H, et al. Association Between Acid Reflux Medication and Supraglottoplasty in Infant Laryngomalacia. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40440010. doi:10.1001/jamaoto.2025.1201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。